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Pre‑ and postmenopausal women 
have different core urinary 
microbiota
Nadia Ammitzbøll1,2, Benedikt Paul Josef Bau3, Caspar Bundgaard‑Nielsen1,2, 
Annemarie Brusen Villadsen1,2, Ann‑Maria Jensen1, Peter Derek Christian Leutscher1,2, 
Karin Glavind2,4, Søren Hagstrøm1,2,5, Louise Thomsen Schmidt Arenholt1,2,3 & 
Suzette Sørensen1,2*
Recent studies suggest that alterations in the female urinary microbiota is associated to development 
of bladder disease. However, the normal microbiota composition and variation in healthy women 
are poorly described. Moreover, the effects of hormonal changes on microbiota during menopause 
is not well understood. The aim of our study was to investigate the urinary microbiota in healthy 
pre‑ and postmenopausal women without urinary tract symptoms. Microbiota composition in 
catheterized urine samples was mapped using 16S rRNA gene sequencing. In total, 41 premenopausal 
and 42 postmenopausal women were initially included. Samples with first PCR amplification 
concentration below level of the negative control were excluded, resulting in 34 premenopausal 
and 20 postmenopausal women included in data analysis. Urine from postmenopausal women 
showed significantly higher alpha diversity compared to premenopausal women. Lactobacillus 
was the most abundant bacteria in both groups, however the relative abundance of Lactobacillus 
accounted for 77.8% in premenopausal versus 42.0% in postmenopausal women. In conclusion, urine 
from premenopausal mostly presented with Lactobacillus dominated urotypes, whereas urine from 
postmenopausal women presented a more diverse urinary microbiota with higher abundance of the 
genera Gardnerella and Prevotella. The clinical and pathophysiological implications of this difference 
remain to be elucidated.
The human urinary microbiota has recently received much attention in connection to bladder health and func-
tion. Based on standard culturing methods, urine from healthy bladders has traditionally been considered sterile. 
Application of more sensitive and specific techniques, such as next generation sequencing and enhanced urine 
culturing, has revealed the presence of a naturally dwelling bacterial community in urine from healthy individu-
als without urinary tract  symptoms1–4. Previous studies have reported that the female urinary microbiota can be 
divided into different urotypes, depending on their dominant bacterial genera. Some disagreement exists regard-
ing the number of urotypes, depending on collection and analysis  methods5–9. However, the studies agree that the 
majority of women have a urotype dominated by Lactobacillus, together with other common bacteria, including 
Gardnerella, Prevotella, and Streptococcus1,2,9,10. The function and implications of the urinary microbiota is largely 
unexplored. However, the first studies are emerging, pointing towards an association between a dysbiotic urinary 
microbiota and bladder disorders such as urgency urinary incontinence (UUI)5,11–13, overactive bladder (OAB)14, 
neuropathic  bladder15, and recurrent urinary tract infections (rUTI)16. Whether there is a causal relationship 
between this altered microbiota and urinary tract disease remains unknown.
UUI, OAB, and rUTIs are common in women of all ages, with an increased risk after  menopause17–19. The 
underlying etiology is unclear, however, a plausible explanation may be found in possible age- or hormonal 
status dependent differences in the urinary  microbiota9,20–22. Microbiota alterations in relation to age and/or 
hormone changes during menopause have been observed in other microbial niches such as the gut and vaginal 
 microbiota23,24. In the vaginal microbiota, a study reported that the bacterial composition was dependent on 
menopausal status, in which Lactobacillus was more dominant in pre- and perimenopausal women compared 
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to postmenopausal  women24. Additionally, local vaginal estrogen treatment in postmenopausal women have 
shown increased level of Lactobacillus in the  vagina25 and the  bladder26. Both local vaginal estrogen treatment 
and treatment with Lactobacillus supplements in patients suffering from rUTIs reduces the risk of  infections25,27,28. 
Together, this indicate a possible role of estrogen level on the urinary microbiota composition. Therefore, we 
aimed at investigating the female urinary microbiota in healthy pre- and postmenopausal women to study if the 
urinary microbiota of the bladder varies with age and/or menopausal status.
Results
In this study, 87 women were included of which 43 were premenopausal women and 44 postmenopausal women. 
Four women were subsequently excluded based on a positive standard urine culturing, leaving 41 premenopausal 
(mean age 37 ± 9.5 years) and 42 postmenopausal (mean age 63 ± 6.9 years) women in the final study. All women 
were ethnic Danes. Characteristics such as BMI and smoking status were comparable between the two groups 
(Table 1). The postmenopausal women had a higher mean number of total births but less caesarean sections 
compared to premenopausal women.
DNA purification from the urine samples showed presence of DNA, albeit for some samples at low concentra-
tions, ranging from below 1 ng/mL urine to 15,000 ng/mL urine. To avoid miss- or over-interpretation of bacte-
rial status, the DNA concentration was subsequently evaluated after the initial PCR during library preparation 
for 16S ribosomal RNA (rRNA) gene sequencing. Samples that produced lower DNA concentrations following 
library generation, compared to the negative controls, were excluded in all subsequent analyses (supplementary 
Fig. S1a). This resulted in urine samples from 29 women being excluded, leaving 34 women in the premenopausal 
group and 20 women in the postmenopausal group in the data analysis. Subgroup analyses revealed that the 
excluded women were older (p = 0.021), contained fewer active smokers (p = 0.036 and 0.030 for all women and 
postmenopausal women only, respectively), and that there was a higher proportion of postmenopausal women 
among the excluded women compared to the included women (p = 0.017). No differences were observed in 
BMI and age after accounting for the variation in number of premenopausal and postmenopausal women (sup-
plementary Fig. S2). After removal of these samples, quality filtering, and chimera removal, a total of 2,467,401 
reads were obtained with a mean number of 24,674.01 reads per sample. A total of 2,449 unique Operational 
Taxonomic Units (OTUs) were identified, with 93.14% being identified at the phylum taxonomic level, 50.84% 
at the genus level, and 0.08% at the species level. A rarefaction curve showed good sequencing coverage (sup-
plementary Fig. S1b).
The urinary microbiota in premenopausal women is different from that of postmenopausal 
women. When comparing the bacterial composition in urine from premenopausal women with that of post-
menopausal women, we observed a statistically significant difference in alpha diversity. A significantly lower 
OTU richness (p = 0.004), Pielou evenness (p = 0.010), and Shannon diversity index (p = 0.005) was observed 
in the urine of premenopausal women compared to that of postmenopausal women (Fig. 1a–c). Beta diver-
sity was analyzed, using Principal Coordinates Analysis (PCoA), showing a segregation of pre- and postmeno-
pausal women (Fig. 2a). We investigated the resulting clusters using hierarchical cluster analysis and observed 
that the urinary microbiota separated into three distinct urotypes. Two of the urotypes were predominantly 
found amongst premenopausal women, whereas the last urotype was mostly observed amongst postmenopausal 
women (Fig. 2c). Heatmap representation of the 20 most abundant genera showed that urine of both the pre- and 
postmenopausal women were dominated by the Lactobacillus genus (Fig. 2b), however, the relative abundance 
of these were markedly lower in the postmenopausal women (42.0%) compared to the premenopausal women 
(77.8%, Benjamin-Hochberg corrected p value < 0.01). Instead, the postmenopausal women appeared to have a 
broader representation of different bacteria, as supported by the higher alpha diversity, including higher relative 
abundances of Gardnerella, Prevotella, Escherichia-Shigella, Atopobium, Streptococcus, and Dialister.




n = 41 (49.4%)
Postmenopausal
n = 42 (50.6%)
Age
Range 18 – 49 55 – 81
Mean (Years (± SD)) 37.2 (± 9.5) 63.3 (± 6.9) p = 4.35 × 10−15
BMI
Mean (kg/m2 (± SD)) 26.4 (± 5.2) 25.8 (± 4.4) p = 0.067
Smoking status (n (%))
Never 19 (46.3%) 29 (69.0%) p = 0.095
Previously 17 (41.5%) 11 (26.2%) p = 0.095
Currently 5 (12.2%) 2 (4.8%) p = 0.095
Total births (n(± SD))
Mean births 1.6 (± 1.2 SD) 2.5 (± 1.0 SD) p = 0.002
Mean caesarean section 0.4 (± 0.7 SD) 0.2 (± 0.7 SD) p = 0.039
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Since we observed different urotypes in the two groups, we analyzed pre- and postmenopausal women sepa-
rately, to determine if variations in core microbiota existed within the groups.
Hierarchical cluster analysis demonstrated that the bacterial composition of the premenopausal women sepa-
rated into three urotypes (Fig. 3a). In urotype I, representing the majority of premenopausal women, Lactobacillus 
was the primary genus accounting for a high relative abundance with a small contribution from Gardnerella 
(Fig. 3b). The second urotype, urotype II, was likewise dominated by Lactobacillus (Fig. 3c) with secondary con-
tributions from Flavobacterium, Ureaplasma, and Enhydrobacter. In addition to these Lactobacillus-dominated 
urotypes, a third urotype, urotype III, appeared with a more mixed bacterial distribution (Fig. 3d).
The postmenopausal women were similarly grouped into two separate urotypes (Fig. 4a). The first urotype of 
postmenopausal women, urotype IV, showed high similarity to urotype I and II for premenopausal women by 
Figure 1.  Alpha-diversity of the urinary microbiota in pre- and postmenopausal women depicted using (a) 
Number of observed OTUs, (b) Pielou’s evenness index, and (c) Shannon diversity index.
Figure 2.  The bacterial composition in urine samples from pre- and postmenopausal women. (a) PCoA plot 
using Bray Curtis dissimilarity. Three urotypes were identified, as indicated with green, purple and orange 
circles. (b) Heatmap, indicating the 20 most abundant bacterial genera in the urine, as well as percentage of 
total OTUs. Red and blue respectively indicates high and low relative abundance. *Benjamin Hochberg adjusted 
p value < 0.01. (c) Dendrogram obtained with hierarchical clustering of OTU diversity in samples, based on 
the PCoA plot. Branch colors represent urotype, while label color represent menopausal state: red indicate 
premenopausal women, whereas blue represent postmenopausal women.
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being highly dominated by Lactobacillus (Fig. 4b). In contrast, the second urotype, urotype V, was defined by a 
highly diverse bacterial composition with less abundant Lactobacillus and higher contributions from Gardnerella, 
Escherichia-Shigella, Prevotella, Streptococcus, Dialister, Atopobium, and Flavobacterium (Fig. 4c).
To evaluate whether differences in age, and thereby proximity to menopause, could explain what urotype 
defined the women, we compared the mean ages of the participants in each urotype. There was no significant 
difference in the mean age between premenopausal women with urotype I, II, or III (Fig. 5a), indicating that 
the low-Lactobacillus profile observed in urotype III was not associated with age. Conversely, the two urotypes 
observed amongst the postmenopausal women appeared to be defined by age (p = 0.041, Fig. 5a) but not by time 
since last menstruation (Fig. 5b). This indicates that after menopause, the age of the women may influence the 
composition of the urinary microbiota.
Discussion
The composition and normal variation in the urinary microbiota throughout life in healthy women is poorly 
described, and the effects of hormonal changes, especially during menopause, is not well understood. Our study 
showed that pre- and postmenopausal women have different core urinary microbiotas, with a predominance 
of Lactobacillus in both groups, but a lower abundance of Lactobacillus together with more mixed composition 
in postmenopausal women. Our results are partly in line with previous studies detecting the bacterial popula-
tion in healthy females, showing that the urinary microbiota of healthy women is dominated by a few genera, 
including Lactobacillus, Gardnerella, and Prevotella3,5,10,11,15,28. These studies, however, vary in age criteria for 
study participants and often describe a mixed representation of women ranging from young premenopausal 
women to late postmenopausal women. Similar to our study, Price et al.9 compared the urinary microbiota from 
catheterized samples between pre- and postmenopausal women. They reported Lactobacillus to be the most 
common urotype (defined by > 50% relative abundance), however, it appeared that this was not associated with 
age or menopausal status. The reason for this discrepancy between their and our results are unknown, but it may 
be explained by differences in age or ethnicity. Moreover, methodical differences may also explain some of the 
differences, as Price et al.9 included enhanced bacteria culture together with their 16S rRNA gene sequencing 
Figure 3.  The bacterial composition in urine samples from premenopausal women. (a) Dendrogram obtained 
with hierarchical clustering of OTU diversity in samples. Three urotypes were identified, with green, purple and 
orange branches representing urotype I, II, and III respectively. (b–d) Heatmaps showing the 20 most abundant 
bacterial genera in the three urotypes, I, II and III. The premenopausal donors 2, 4, and 6 were not placed in any 
clusters by the unsupervised clustering algorithm used.
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Figure 4.  The bacterial composition in urine samples from postmenopausal women. (a) Dendrogram obtained 
with hierarchical clustering of OTU diversity in samples. Two urotypes were identified, with grey and mangenta 
colored branches representing urotype IV and V respectively. (b,c) Heatmaps showing the 20 most abundant 
bacterial genera in the two urotypes.
Figure 5.  Demographics of the urotypes from pre- and postmenopausal women. (a) Age of the different 
urotypes in pre- and postmenopausal women. (b) Months since last menstruation for postmenopausal women. 
* p = 0.041.
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results. In contrast, we only used 16S rRNA gene sequencing and some bacteria may therefore be differentially 
detected. As an example, in the culture data from Price et al.9 they found a high number (9.4%; defined by > 50% 
relative abundance) of women with a Streptococcus dominated urotype, whereas we only identified one woman 
(1.2%) in our study, with > 40% relative abundance of Streptococcus. However, similar to our results, the 16S 
rRNA gene sequencing data from Price et al.9 reported lower relative abundance of Streptococcus, indicating that 
methodically differences highly impact the results.
It is well known that low alpha diversity, with predominant Lactobacillus colonization of the vaginal flora is 
imperative for vaginal  health29,30 and that a reduction in Lactobacillus abundance may cause vaginal  disease30. 
Since the vaginal and urinary microbiotas appear to have functional and structural  overlaps31 it is reasonable 
to presume that a urotype with low relative abundance of Lactobacillus in urine, may be an indicator of bladder 
dysbiosis and therefore constitutes an increased risk of developing bladder disorders. In our study, the major-
ity of the premenopausal women belonged to one of two urotypes characterized by high relative abundance of 
Lactobacillus; however, we observed a small subgroup of participants belonging to a more mixed urotype, with 
a lower relative abundance of Lactobacillus. This could represent a dysbiotic urinary microbiota putting these 
women in higher risk of experiencing future bladder related diseases. In line with this, younger women with a low 
or moderate-Lactobacillus dominated urotype have been found to be associated with mixed urinary incontinence, 
pointing towards a dysbiosis in women lacking Lactobacillus32. Conversely, it might represent personal variations 
in the urinary microbiota or be influenced by temporal factors that could change the microbial composition, 
such as menstruation or  coitus33.
The menopausal reduction of estrogen has been shown to cause a decrease in the level of free glycogen in the 
vaginal epithelium in postmenopausal  women34. As glycogen serves as nutrition for the Lactobacillus, a reduced 
level of Lactobacillus in the vagina is  observed34,35. Therefore, transition to a less Lactobacillus dominated urotype 
in postmenopausal women might be a result of decreasing levels of  estrogen24. In our study, the postmenopausal 
women with the Lactobacillus dominated urotype, urotype IV, were significantly younger than the women in 
urotype V. However, this was not related to time since last menstruation, and it is thus unclear if the bacterial 
variations was related to fluctuations in hormonal levels. Studies investigating the direct role of estrogen on the 
urinary microbiota are thus urgently needed, in order to evaluate the role of hormonal changes on the bacterial 
composition in the bladder.
UUI, OAB and other lower urinary tract symptoms are common in elderly women affecting around 12–55%18 
and the cause behind this may be the altered urinary microbiota following  menopause36. When looking at the 
vaginal microbiota, women with lack of Lactobacillus spp., especially the loss of peroxide-producing Lactobacilli, 
have increased risk of genital disease, including bacterial vaginosis, increased risk of susceptibility of sexually 
transmitted infections, pre-term delivery, miscarriage, and pelvis inflammatory  disease37,38. If the same is true for 
the urinary microbiota, decrease in Lactobacillus abundance could make the women more prone to urinary tract 
disorders. Previous  studies5,6,39 have reported an altered bacterial composition in women suffering from UUI, 
characterized by a more diverse and rich bacterial composition, higher abundance of Gardnerella, and signifi-
cantly decreased Lactobacillus compared to healthy controls. These results match our findings in the postmeno-
pausal group. Neither Pearce et al.5 nor Thomas-White et al.6 used age- and menopausal status matched controls 
for the two groups (women with UUI being significantly older), and the observed variations may therefore reflect 
age differences rather than disease state. Furthermore, Price et al.39 utilized expanded quantitative urine culture 
to asses bacterial abundance, which has been demonstrated to result in different bacterial compositions of urine 
compared to 16S rRNA gene  sequencing9. Intriguingly, the urinary microbiota profile of the postmenopausal 
women in our study bear high resemblance to what has been reported for the women with  UUI5,6. Notably, in a 
study by Karstens et al.11 using age- and menopausal matched controls, they did not find any difference in alpha 
diversity or in relative abundances of Gardnerella and Lactobacillus between UUI patients and controls. Larger 
studies, however, on UUI are needed to conclude on a role of the urinary microbiota in UUI disease. Our study 
demonstrates that age and menopausal status should be considered in future studies on urinary microbiota and 
that pre- and postmenopausal women cannot be compared to each other due to significant different microbiota 
composition.
A number of limitations in our study need to be addressed. First, four asymptomatic women were excluded 
based on a positive standard urine culture. Uropathogens, specially E.coli, has however been found above the 
typical threshold in asymptomatic women in the study by Price et al.40, indicating that exclusion of these four 
women could have impacted our results. In future studies, one should include women with a positive standard 
urine culture if they have no clinical symptoms of urinary tract infection. Second, the use of 16S rRNA gene 
sequencing only allowed us to reliably classify bacteria at phylum and genus level, and specific variation at spe-
cies level was therefore not evaluated. Studies have previously implicated Lactobacillus species, like L. gasseri 
and L. iners, to play a function in bladder diseases such as UUI and neuropathic  bladder5,41, indicating that dif-
ferent Lactobacillus species may have different functional effects on bladder health. Third, use of 16S rRNA gene 
sequencing and enhanced bacteria culture may give different urinary microbiota  results9 and one may argue that 
both methods should be included to proper reflect the microbiota of the bladder. Fourth, we only collected urine 
at a single timepoint, and as the bacterial composition has been shown by some to fluctuate over  time33, this 
possible lack of temporal stability may have impacted the results. We have, however, previously shown that the 
composition of the urinary microbiota remains stable over a shorter time  period42. Finally, we did not account 
for other factors that could potentially influence the urinary microbiota, such as  diet43, fluid intake, urinary 
oxygen  concentrations44, menstruation  cycle33, sexual  activity33, and vulvo-vaginal  symptoms45,46. This could in 
particular be a limitation since these would be expected to differ highly between our two groups.
However, this study also has strengths. This is one of the first studies investigating a difference between pre- 
and postmenopausal women using catheterized urine samples instead of midstream urine samples, minimizing 
vulva-vaginal  contamination1,47 and thereby likely giving a more representative picture of the urinary microbiota. 
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For instance, a relatively high number of samples were excluded due to DNA concentrations being below negative 
control cut-off levels (after the initial PCR reaction in library preparation). This is consistent with other studies 
investigating urine obtained by transurethral  catheterization1,5,6,12, and may not be a technical issue, but rather 
reflect a biologically relevant variation in urinary bacterial content. Importantly, the excluded women were older 
and less likely to be smokers, which corroborate this theory. Studies using voided urine, in contrast, obtained a 
higher bacterial DNA  yield2,48,49, suggesting contamination with urethral bacteria. Moreover, in our statistical 
analyses possible confounders including smoking status, age, and BMI have been taken into account, increasing 
the strength of the study. Additionally, we included duplicates of our urine samples increasing the reproducibility 
of our results. Finally, the characterization of study participants regarding in- and exclusion criteria is highly 
well defined; e.g. by the use of two validated symptom questionnaires.
Conclusion
This study demonstrated that pre- and postmenopausal women overall possess different urinary microbiotas. 
Urine from women prior to menopause was dominated by Lactobacillus whereas postmenopausal women tended 
to display a more diverse urinary microbiota. Moreover, in healthy women, a normal variation in urinary micro-
biota might be present and a shift in urinary microbiota may occur during menopause that need to be empha-
sized when investigating dysbiosis of the bladder. Results from our study extend the knowledge of the normal 
microbiota in women and the role of age and/or menopausal stage on the microbial composition.
Methods
Study participants and clinical data. Women were recruited by advertisement on social medias and in 
the newspaper. The study was approved by The North Denmark Region Committee on Health Research Ethics 
(N-20170050) and all women provided informed consent. The investigation was conducted according to the 
principles expressed in the Declaration of Helsinki. The study was registered at the Danish Data Protection 
Agency.
The premenopausal group consisted of non-pregnant women aged 18–50 years, while postmenopausal women 
were aged > 55 years and without vaginal bleedings within one year of study inclusion. Exclusion criteria for 
both groups included bladder symptoms, antibiotic treatment within three months prior to inclusion, recurrent 
cystitis (> 2 per year) or current UTI evaluated by a positive urine culture of the collected urine sample. For the 
postmenopausal group, use of hormonal replacement therapy (oral and topical) was considered an exclusion 
criterion. Clinical assessment of bladder symptoms was evaluated by two questionnaires designed to measure 
frequency and severity of urinary incontinence; the International Consultation on Incontinence Questionnaire 
(ICIQ) Urinary Incontinence Short Form (ICIQ-UI-SF)50 and Overactive Bladder (ICIQ-OAB)51. Additional 
data was collected, including menstrual status, use of hormonal contraceptives, BMI, age, caesarean section, 
and previous births.
Urine collection. All samples were collected at the Department of Obstetrics and Gynecology, North Den-
mark Regional Hospital, using a CH/FR 12/4.0 mm urinary catheter (SpeediCath, Coloplast Denmark) for ster-
ile intermittent catheterization. Prior to catheter insertion, the urethral meatus was cleaned with sterile water. 
Urine was collected in a 50 mL collection tube, aliquoted into 10 mL fractions within 15 min, and immediately 
placed at -80 °C until further processing. Ten mL of urine was collected in a Urine Monovette with boric acid 
(Saarstedt, Germany) for standard urine culture at the Department of Clinical Microbiology, Aalborg University 
Hospital.
DNA extraction. From 10 mL of urine, bacterial DNA was isolated using the QIAamp Viral RNA Mini 
Kit (Qiagen) according to manufacturer´s recommendations, modified with a pre-treatment step, as previously 
 explained42. All samples were extracted and analyzed as duplicates. Briefly, before DNA extraction, urine sam-
ples were centrifuged at 3,220 × g for 20 min. Pellets were resuspended in lysis buffer and a bead beating step 
was included using the TissueLyser LT (Qiagen) for 2 min at 30 Hz with a 5 mm stainless steel bead. DNA yield 
was measured by fluorometric quantification using the Qubit 4 Fluorometer (Thermo Fisher) with the Qubit 
dsDNA Broad Range Assay Kit (Thermo Fisher). Reagent and procedure contamination controls were included 
by performing the DNA extraction on Nuclease-free water.
16S rRNA Gene Sequencing and bioinformatics. Bacterial composition of urine samples were evalu-
ated by 16S rRNA gene sequencing, targeting the V4 hypervariable region, on the Illumina MiSeq platform. 
Library preparation and sequencing was performed by DNASense (Denmark), as previously  described52, 
using ≤ 5 ng/µL DNA for library preparation. For error rate estimation during sequencing, a 20% PhiX control 
library (Illumina) was used. A second negative control, consisting of nuclease-free water, was sequenced to elim-
inate background contaminants. Finally, a positive control (complex bacteria sample obtained from an anaerobic 
digester system) was used to monitor sequencing efficiency and minimize batch effects.
Forward reads were trimmed for quality using Trimmomatic v. 0.3253 utilizing settings: SLIDINGWIN-
DOW:5:3 and MINLEN:250 to remove poor quality reads and discard reads < 250 bp in length. Reads were 
dereplicated and processed using the UPARSE  pipeline54. Dereplicated reads were clustered using the usearch v. 
7.0.1090 command “-cluster_OTUs” with default settings, and OTUs were formed based on 97% identity, using 
the “-usearch_global”. Finally, bacterial taxonomy was assigned using the RDP  classifier55, with the command 
“parallel_assign_taxonomy_RDP.py” in  QIIME56 and the MiDAS database v.1.2057.
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Statistics. Data analysis was performed using R version 3.6.158 through the Rstudio IDE (http://www.rstud 
io.com/). 16S rRNA data was analyzed using the ampvis2 package v.2.4.1259. Alpha diversity was determined 
using OTU richness and Shannon diversity index, whereas β diversity was determined using PCoA based on 
Bray–Curtis distance measures. To further analyze differences and similarities, we performed unsupervised 
hierarchical cluster analysis on the Euclidian distance between OTUs, and visualized the results with dendro-
grams, using the dendextend package v. 1.13.260. This dendrogram was furthermore used to classify urotypes. 
To determine OTUs with statistically significant distributions in pre- and postmenopausal women, we used the 
DESeq2 package v.1.24.061 to generate multiple hypothesis corrected p values using the Benjamini–Hochberg 
 procedure62.
For continuous data, like OTU richness, Shannon diversity index, age etc., distribution and variance were 
assessed using Shapiro-Wilks test and Bartlett’s test, respectively. Normal distributed data with equal variance 
were compared using Student´s t-test or ANOVA followed by Tukeys post hoc test. Non-parametric data were 
compared using Mann–Whitney-Wilcoxon test or Kruskall-Wallis test followed by Dunn’s post hoc test. A p 
value of < 0.05 was considered significant for all statistic tests, whereas for multiple hypothesis corrected p values, 
a padj of < 0.01 was required.
Data availability
All data generated or analyzed in the study, are included in this published article and its supplementary informa-
tion files. Sample information (supplementary_metadata) and OTU-tables (Supplementary_Otutable) generated 
during sequencing and used for bioinformatics are included as supplementary files.
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